Category: Workers Comp

593 posts found

FDA Approves Rextovy as OTC for Opioid Overdose

This approval marks the third OTC naloxone medication available for the treatment of opioid overdose.

Deep Breath: Occupational Lung Disease and Pharmacy Management

These diseases are infrequent, but they can incur significant costs as they can be present for life, requiring ongoing monitoring, treatment, and medication.

Image of A doctor handing a patient medication

Legislation & Policy

State Activity Surrounding Physician Dispensing

Florida, Pennsylvania, and Michigan have recently made waves regarding physician dispensing.

Industry Insights

Migraine Drugs Are Now Number Three in Drug Spend in California

While migraine drugs make up less than 1% of prescriptions, they now make up 7.5% of drug spend, primarily driven by CGRP drugs.

Psychedelic Updates

Emerging Therapies: Phase 3 Data for LSD-Based Drug in Major Depression

Patients taking DT120 for major depressive disorder experienced significant drops in depression symptoms.

Healthe Developments

Healthesystems at WCI 2026

Visit Healthe at Booth #921, and don’t forget to check out two educational sessions featuring Healthe leaders!

Medmonitor

Can GLP-1 Drugs Lower Cancer Risks?

While experts agree more research is needed, several studies have noted patients on these drugs showed reduced rates of certain types of cancer.

This Month's Must Read

Escalating Costs: Trends in Durable Medical Equipment (DME)

Demand for DME is rising, as are costs. What’s driving this growth, and how can the workers’ compensation industry contain costs?

image that represents state legislatures

Legislation & Policy

Presumption Expansions Throughout the Country

Several states continue to update presumptions for cancer, PTSD, and other conditions.

image of cream someone rubs on their skin for pain

Industry Insights

WCRI Publishes Report on Drug Payment Trends

Dermatological agents remained a significant cost driver, in part due to physician dispensing and delivery pharmacies, which accounted for a significant number of high-cost transactions.

Psychedelic Updates

States Continue to Push for Psychedelic-Assisted Therapy Programs

Connecticut, Georgia, and Oklahoma enacted laws to enable certain programs, while a Louisiana bill awaits gubernatorial decisions.

This Month's Must Read

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.

Industry Insights

WCRI Publishes 2026 CompScope Benchmarks

Claim costs increased 6% per year from 2022-2025 in the median study state, with state-level variations.

Psychedelic Developments

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.

Legislation & Policy

Texas Approves Audit of Topical Analgesics

After soliciting stakeholder feedback on possible audit topics, the DWC prioritized a study of topical analgesics by the Medical Quality Review Panel.

1 2 3 4 5 … 36 37 38 39 40 Next